Sign in

NCT06944405Not yet recruiting

Implementation for Heart Failure Therapies Post-discharge Followed by CardiOSIgnal at HOME

Source: ClinicalTrials.gov · Last updated 25 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

CardioSignal technology (mechanocardiography) could enable home follow-up after admission for acute heart failure, thus improving guidline-directed medical therapies for heart failure dose escalation while reducing the logistical constraints and stress associated with frequent hospital visits. The intended purpose is to detect signs of HF in adults (aged 18 years or older and \< 85 years)

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
65 (estimated)
First submitted
15 Apr 2025
Start date
10 May 2025
Primary completion date
31 Jan 2026
Lead sponsor
Precordior Ltd
NCT number
NCT06944405

What you commit to

  • Study type: Interventional
  • Planned participants: 65
  • From 10 May 2025 to the primary completion date, 31 Jan 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous history of allergic asthma at an early age.

Other illness

  • Patients with a history of pulmonary embolism.
  • Cardiorespiratory disorders which may be aggravated by the slight compression of the thorax. (patient with a pacemaker).
  • Known allergies for: bisoprolol, ramipril, Entresto, spironolactone, empagliflozine, dapagliflozine.

Age

  • Patients \<18 years and \>85 years.

Other

  • Pregnant women. lactating woman.
  • The participant's inability to adhere to study procedures or give informed consent.

Who the study is looking for

  • Patients admitted at emergency room for acute heart failure.
  • Patients discharged from emergency room after an episode of acute heart failure.
  • Either LVEF\>40% or ≤40%, either known or assessed during the index hospitalization (however at least 1/3 of patients are required from each category).
  • BNP \> 200 pg/ml OR NT-ProBNP \> 800 pg/ml
  • Patients with connected smartphone.

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Fattouma Bourguiba University Hospital, Emergency department
Coordinator of this site? Confirm its status
MonastirTunisiaUnknown status
Sahloul Hospital, Emergency department
Coordinator of this site? Confirm its status
SousseTunisiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.